Rossari Biotech

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
609.30
8.3 (1.38%)
BSENSE

Dec 05

BSE+NSE Vol: 15.93 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
586.11
543.72
579.56
512.73
498.35
489.65
472.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
586.11
543.72
579.56
512.73
498.35
489.65
472.72
Raw Material Cost
407.21
334.40
369.77
321.48
324.36
284.03
303.94
Purchase of Finished goods
29.39
28.96
33.88
45.99
42.34
42.55
38.67
(Increase) / Decrease In Stocks
-35.75
7.99
-2.01
-17.42
-26.00
14.31
-4.34
Employee Cost
37.80
37.47
35.49
35.69
32.56
28.58
25.04
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
0.00
0.00
0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
75.53
67.04
72.93
62.23
59.15
55.29
45.82
Total Expenditure (Excl Depreciation)
514.19
475.86
510.07
447.97
432.41
424.77
409.13
Operating Profit (PBDIT) excl Other Income
71.92
67.86
69.49
64.76
65.94
64.88
63.59
Other Income
1.60
1.20
1.79
0.55
0.72
0.95
0.39
Operating Profit (PBDIT)
73.52
69.06
71.28
65.31
66.66
65.83
63.98
Interest
6.09
5.73
5.50
4.94
3.68
3.69
2.52
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
67.43
63.33
65.78
60.37
62.98
62.14
61.46
Depreciation
18.23
17.75
18.22
18.32
15.16
15.37
16.07
Profit Before Tax
49.67
46.10
47.71
42.38
48.11
46.99
45.57
Tax
12.80
12.50
13.26
10.68
12.78
12.09
11.44
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.41
33.08
34.29
31.37
35.04
34.69
33.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.41
33.08
34.29
31.37
35.04
34.69
33.95
Share in Profit of Associates
0.47
0.52
0.15
0.33
0.29
0.21
0.18
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
36.88
33.60
34.44
31.70
35.33
34.90
34.13
Equity Capital
11.07
11.07
11.07
11.07
11.06
11.05
11.05
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.66
6.07
6.22
5.73
6.39
6.32
6.18
Diluted Earnings per share
6.65
6.06
6.21
5.72
6.38
6.3
6.17
Operating Profit Margin (Excl OI)
12.27%
12.48%
11.99%
12.63%
13.23%
13.25%
13.45%
Gross Profit Margin
11.5%
11.65%
11.35%
11.77%
12.64%
12.69%
13.0%
PAT Margin
6.29%
6.18%
5.94%
6.18%
7.09%
7.13%
7.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 7.80% vs -6.18% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 9.76% vs -2.44% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 5.98% vs -2.35% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 6.28% vs 4.18% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Rossari Biotech With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
586.11
123.52
462.59
374.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
586.11
123.52
462.59
374.51%
Raw Material Cost
407.21
61.99
345.22
556.90%
Purchase of Finished goods
29.39
1.24
28.15
2,270.16%
(Increase) / Decrease In Stocks
-35.75
-8.36
-27.39
-327.63%
Employee Cost
37.80
14.95
22.85
152.84%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
-0.01
0.02
200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
75.53
31.49
44.04
139.85%
Total Expenditure (Excl Depreciation)
514.19
101.30
412.89
407.59%
Operating Profit (PBDIT) excl Other Income
71.92
22.22
49.70
223.67%
Other Income
1.60
1.01
0.59
58.42%
Operating Profit (PBDIT)
73.52
23.23
50.29
216.49%
Interest
6.09
0.51
5.58
1,094.12%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
67.43
22.72
44.71
196.79%
Depreciation
18.23
9.05
9.18
101.44%
Profit Before Tax
49.67
13.66
36.01
263.62%
Tax
12.80
3.75
9.05
241.33%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
36.41
9.92
26.49
267.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
36.41
9.92
26.49
267.04%
Share in Profit of Associates
0.47
0.00
0.47
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
36.88
9.92
26.96
271.77%
Equity Capital
11.07
23.39
-12.32
-52.67%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.66
4.24
2.42
57.08%
Diluted Earnings per share
6.65
4.24
2.41
56.84%
Operating Profit Margin (Excl OI)
12.27%
17.99%
0.00
-5.72%
Gross Profit Margin
11.50%
18.39%
0.00
-6.89%
PAT Margin
6.29%
8.03%
0.00
-1.74%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 586.11 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 7.80% vs -6.18% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 17.61% vs 3.08% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 36.88 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 9.76% vs -2.44% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 4.39% vs 7.22% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 71.92 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.98% vs -2.35% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 9.07% vs 3.74% in Sep 2024

Quarterly - Interest
Interest 6.09 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 6.28% vs 4.18% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 65.49% vs -26.84% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.27%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024